Local telemedicine services, such as Doctor Anywhere, provide a convenient platform for consultations regarding diabetes and weight loss management, including the use of GLP-1 medications
Nonetheless, in the initial months following its introduction in Israel, it is anticipated that Wegovy will solely be available in the private market, and primary care physicians in health funds will not have the option to prescribe it to patients who are interested
A Phase 2 trial published in The New England Journal of Medicine in 2023 enrolled 338 adults with obesity
Reasons may include: Dose too low Irregular injection schedule Diet and lifestyle inconsistencies Underlying hormonal or metabolic issues If progress is slower than expected, a provider may review: Relevant labs and health markers Medication tolerance and dosing Nutrition, movement, sleep, and stress patterns Whether the care plan should continue, change, or stop This is why provider-guided monitoring can help personalize care and support safer treatment decisions
"This is not a replacement for trials, but it can move much faster, and that speed matters when a drug goes from niche to mainstream almost overnight." Leveraging AI to analyze social media Until now, the most challenging part of this process, which Guntuku calls "computational social listening," has been scale
